Background: Regular activity breaks positively impact markers of cardiometabolic health when performed in a laboratory. However, identifying compliance to a free-living regular activity breaks intervention is challenging, particularly if intensity is prescribed. Methods: This study had two parts. In Part A, 20 participants performed activity breaks similar to those shown to impart health benefits while wearing an ActiGraph and activPAL accelerometer, and a heart rate monitor. In Part B, the threshold found to identify these activities was used to identify the activity breaks performed by 78 sedentary, university employees wearing an ActiGraph accelerometer for seven days. Results: A cut-point of 1,000 vector magnitude counts per minute accurately identified activity breaks performed in the laboratory. Applying this cut-point to data collected in free living, sedentary participants identified, on average, seven activity breaks were being performed during work-hours. Conclusions: Using a cut-point of 1,000 vector magnitude counts per minute will identify activity breaks of a similar intensity to those found to elicit acute cardiometabolic benefit. Sedentary university employees may benefit from interventions to increase the number of activity breaks performed across their entire day.
Meredith C. Peddie, Matthew Reeves, Millie K. Keown, Tracy L. Perry and C. Murray Skeaff
Kirsty A. Fairbairn, Ingrid J.M. Ceelen, C. Murray Skeaff, Claire M. Cameron and Tracy L. Perry
Vitamin D insufficiency is common in athletes and may lower physical performance. Many cross-sectional studies associate vitamin D status with physical performance in athletes; however, there have been few prospective randomized controlled trials with adequate statistical power to test this relationship, and none in the southern hemisphere. Thus, a prospective double-blind, randomized, placebo-controlled intervention trial was conducted involving 57 professional rugby union players in New Zealand. Participants were randomized to receive 50,000 IU of cholecalciferol (equivalent to 3,570 IU/day) or placebo once every two weeks over 11–12 weeks. Serum 25(OH)D concentrations and physical performance were measured at baseline, weeks 5–6, and weeks 11–12. Mean (SD) serum 25(OH)D concentrations for all participants at baseline was 94 (18) nmol/L, with all players above 50 nmol/L. Vitamin D supplementation significantly increased serum 25(OH)D concentrations compared to placebo, with a 32 nmol/L difference between groups at 11–12 weeks (95% CI, 26–38; p < 0.001). Performance in five of the six tests at study completion, including the primary outcome variable of 30-m sprint time, did not differ between the vitamin D supplemented and placebo groups (p > 0.05). Performance on the weighted reverse-grip chin up was significantly higher in players receiving vitamin D compared with placebo, by 5.5 kg (95% CI, 2.0–8.9; p = 0.002). Despite significantly improving vitamin D status in these professional rugby union players, vitamin D supplementation had little impact on physical performance outcomes. Thus, it is unlikely that vitamin D supplementation is an ergogenic aid in this group of athletes.